243 related articles for article (PubMed ID: 18174452)
21. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
[TBL] [Abstract][Full Text] [Related]
22. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.
Du XL; Edelstein D; Dimmeler S; Ju Q; Sui C; Brownlee M
J Clin Invest; 2001 Nov; 108(9):1341-8. PubMed ID: 11696579
[TBL] [Abstract][Full Text] [Related]
23. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death.
Liu K; Paterson AJ; Chin E; Kudlow JE
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2820-5. PubMed ID: 10717000
[TBL] [Abstract][Full Text] [Related]
24. High-glucose environment induced intracellular O-GlcNAc glycosylation and reduced galectin-7 expression in keratinocytes: Implications on impaired diabetic wound healing.
Huang SM; Wu CS; Chiu MH; Yang HJ; Chen GS; Lan CE
J Dermatol Sci; 2017 Aug; 87(2):168-175. PubMed ID: 28526214
[TBL] [Abstract][Full Text] [Related]
25. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
Marsh SA; Dell'Italia LJ; Chatham JC
Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
[TBL] [Abstract][Full Text] [Related]
26. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes.
Akimoto Y; Hart GW; Hirano H; Kawakami H
Med Mol Morphol; 2005 Jun; 38(2):84-91. PubMed ID: 15944815
[TBL] [Abstract][Full Text] [Related]
27. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
28. Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine.
Nagy T; Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C57-65. PubMed ID: 16107505
[TBL] [Abstract][Full Text] [Related]
29. Glycan-dependent signaling: O-linked N-acetylglucosamine.
Hanover JA
FASEB J; 2001 Sep; 15(11):1865-76. PubMed ID: 11532966
[TBL] [Abstract][Full Text] [Related]
30. O-GlcNAcylation Mediates Glucose-Induced Alterations in Endothelial Cell Phenotype in Human Diabetes Mellitus.
Masaki N; Feng B; Bretón-Romero R; Inagaki E; Weisbrod RM; Fetterman JL; Hamburg NM
J Am Heart Assoc; 2020 Jun; 9(12):e014046. PubMed ID: 32508185
[TBL] [Abstract][Full Text] [Related]
31. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
[TBL] [Abstract][Full Text] [Related]
32. The role of O-linked protein glycosylation in beta-cell dysfunction.
Konrad RJ; Kudlow JE
Int J Mol Med; 2002 Nov; 10(5):535-9. PubMed ID: 12373287
[TBL] [Abstract][Full Text] [Related]
33. Identification of O-GlcNAc modification targets in mouse retinal pericytes: implication of p53 in pathogenesis of diabetic retinopathy.
Gurel Z; Zaro BW; Pratt MR; Sheibani N
PLoS One; 2014; 9(5):e95561. PubMed ID: 24788674
[TBL] [Abstract][Full Text] [Related]
34. Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity.
Chatterjee A; Eshwaran R; Poschet G; Lomada S; Halawa M; Wilhelm K; Schmidt M; Hammes HP; Wieland T; Feng Y
Cells; 2020 Oct; 9(10):. PubMed ID: 33086728
[TBL] [Abstract][Full Text] [Related]
35. Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells.
Matthews JA; Belof JL; Acevedo-Duncan M; Potter RL
Mol Cell Biochem; 2007 Apr; 298(1-2):109-23. PubMed ID: 17136481
[TBL] [Abstract][Full Text] [Related]
36. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
Chatham JC; Nöt LG; Fülöp N; Marchase RB
Shock; 2008 Apr; 29(4):431-40. PubMed ID: 17909453
[TBL] [Abstract][Full Text] [Related]
37. Pleiotropic and age-dependent effects of decreased protein modification by O-linked N-acetylglucosamine on pancreatic β-cell function and vascularization.
Soesanto Y; Luo B; Parker G; Jones D; Cooksey RC; McClain DA
J Biol Chem; 2011 Jul; 286(29):26118-26. PubMed ID: 21622566
[TBL] [Abstract][Full Text] [Related]
38. Proteomic analysis of O-GlcNAc modifications derived from streptozotocin and glucosamine induced beta-cell apoptosis.
Park J; Kwon H; Kang Y; Kim Y
J Biochem Mol Biol; 2007 Nov; 40(6):1058-68. PubMed ID: 18047804
[TBL] [Abstract][Full Text] [Related]
39. Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling.
Cui YL; Xue RQ; Xi He ; Ming Zhao ; Yu XJ; Liu LZ; Wu Q; Si Yang ; Li DL; Zang WJ
Life Sci; 2019 Apr; 222():1-12. PubMed ID: 30786250
[TBL] [Abstract][Full Text] [Related]
40. O-GlcNAc modification of proteins affects volume regulation in Jurkat cells.
Nagy T; Balasa A; Frank D; Rab A; Rideg O; Kotek G; Magyarlaki T; Bogner P; Kovács GL; Miseta A
Eur Biophys J; 2010 Jul; 39(8):1207-17. PubMed ID: 20043149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
